14-day Premium Trial Subscription Try For FreeTry Free
$34.54
-0.0400 (-0.116%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $27.14 $35.40 Friday, 3rd May 2024 AGIO stock ended at $34.54. This is 0.116% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.26% from a day low at $33.63 to a day high of $35.40.
90 days $22.41 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Jan 19, 2022 $31.18 $32.30 $30.77 $31.03 583 900
Jan 18, 2022 $32.71 $32.77 $31.09 $31.14 562 600
Jan 14, 2022 $32.10 $33.26 $31.34 $33.14 500 100
Jan 13, 2022 $31.75 $32.53 $31.17 $31.95 395 800
Jan 12, 2022 $33.02 $33.66 $31.57 $31.64 468 400
Jan 11, 2022 $33.10 $34.20 $32.83 $33.17 411 200
Jan 10, 2022 $32.45 $33.04 $31.04 $33.01 489 200
Jan 07, 2022 $33.45 $34.40 $32.38 $32.57 456 300
Jan 06, 2022 $32.86 $33.84 $31.98 $33.36 388 900
Jan 05, 2022 $33.97 $35.12 $32.81 $32.85 536 200
Jan 04, 2022 $34.58 $34.98 $33.27 $33.79 489 453
Jan 03, 2022 $33.03 $34.85 $32.60 $34.81 325 244
Dec 31, 2021 $33.82 $33.88 $32.81 $32.87 338 514
Dec 30, 2021 $33.67 $34.52 $33.46 $33.57 275 364
Dec 29, 2021 $34.01 $34.37 $33.39 $33.77 284 465
Dec 28, 2021 $34.58 $35.53 $33.85 $34.20 464 002
Dec 27, 2021 $35.63 $35.63 $34.49 $34.71 413 935
Dec 23, 2021 $34.98 $36.08 $34.74 $35.83 423 134
Dec 22, 2021 $34.37 $35.54 $33.96 $35.07 464 941
Dec 21, 2021 $33.88 $34.81 $33.45 $34.58 624 324
Dec 20, 2021 $33.23 $34.36 $31.99 $33.83 922 879
Dec 17, 2021 $31.78 $34.52 $31.32 $33.97 2 973 354
Dec 16, 2021 $32.75 $32.90 $31.25 $31.40 673 947
Dec 15, 2021 $32.13 $32.91 $31.05 $32.76 1 056 739
Dec 14, 2021 $31.32 $32.87 $31.01 $32.23 911 979
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT